Eli Lilly & Co. (Ireland) Ltd. would like to inform you that on the 12th of June 2013, they officially notified the Department of Health and the Irish Medicines Board of the intention to cease supply of Gemzar 200mg and 1g powder for solution for infusion in Ireland due to low volume usage, effective 15th September 2013. They have considered the potential impact of discontinuing this product as part of the decision making process. A number of generic companies market and supply generic gemcitabine in Ireland. Please contact the Lilly Medical Information Department by telephone on (01) 661 4377 or by email to ukmedinfo@lilly.com if you have any questions or if you would like further information.